Efficacy, Safety, and Tolerability of SR750 in Patients With Trigeminal Neuralgia

Summary

The goal of this clinical trial is to evaluate the efficacy，safety and tolerability of SR750 in patients with trigeminal neuralgia (TN). Patients will receive SR750 (study drug) or placebo for 6 weeks and keep a diary of daily pain. The study duration for each patient is up to 11 weeks.

Timeline

Start

2024-09-16

Primary completion

2026-01-26

Completion

2026-02-24

Drugs

Indications